Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial".

Files in This Item:

File	Description	Size	Format
	publisher's version	301.69 kB	Adobe PDF	View/Open

Title:	Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial".
Author(s):	Tits, L.J.H. van (097636649) Graaf, J. de (104035064) Stalenhoef, A.F.H. (068700415)
Publication year:	2005
Document type:	Article / Letter to editor
Journal:	Circulation
ISSN:	0009-7322
Volume:	vol. 111
Issue:	iss. 18
Start page:	p. e284
End page:	p. 5
Subject:	UMCN 2.2: Vascular medicine and diabetes
Organization:	General Internal Medicine
Appears in Collections:	Academic bibliography

Please use this identifier to cite or link to this item: http://hdl.handle.net/2066/48656